GLIOMATCH was featured at the European Cancer Summit 2024, held on 20–21 November in Brussels and online. We’re proud to support Europe’s fight against cancer by equipping clinicians with tools to match patients to the best immunotherapies and track treatment progress.
GLIOMATCH was featured at the European Cancer Summit as part of the Horizon Europe initiative, recognising its role in advancing the EU Mission on Cancer. Horizon Europe, with a €95.5 billion budget for 2021–2027, demonstrates the EU’s commitment to cancer research, including the Cancer Mission, which aims to improve the lives of 3 million people by 2030 through better prevention, diagnosis, treatment, and support for patients and families. GLIOMATCH is part of the Understanding (tumour-host) Interaction Cluster alongside other projects such as ARTURO, HIT-GLIO, MULTIR, THRIVE, and SPACETIME. These projects collaborate to identify common challenges, share best practices, and maximise the impact of their research efforts.
